NCT00343902

Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) Trial

Randomized Clinical Trial of a Crataegus Oxycantha Extract in Chronic Heart Failure

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 120 (planned)
• Sponsor: National Center for Complementary and Integrative Health (NCCIH) · NIH
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To determine the effect of hawthorn extract 450 mg bid vs. placebo, in addition to standard medical therapy in ambulatory patients with NYHA class II to IV chronic heart failure on submaximal exercise as measured by the 6-minute walk test

Detailed description

See Brief Summary

Conditions

• Chronic Heart Failure

Interventions

Type	Name	Description
DRUG	Crataegus Special Extract WS 1442

Timeline

• Start date: 2000-01-01
• Completion: 2004-05-01
• First posted: 2006-06-23
• Last updated: 2006-06-23

Locations

1 site across 1 country: United States